# Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE)

> **NCT03198468** · NA · COMPLETED · sponsor: **Uptake Medical Technology, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Metastatic Lung Cancer
- Lung Cancer

## Interventions

- **DEVICE:** Bronchoscopic Thermal Vapor Ablation

## Key facts

- **NCT ID:** NCT03198468
- **Lead sponsor:** Uptake Medical Technology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-21
- **Primary completion:** 2019-08-20
- **Final completion:** 2019-08-20
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03198468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03198468, "Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03198468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*